Cargando…
Downregulation of promoter methylation gene PRDM5 contributes to the development of tumor proliferation and predicts poor prognosis in gastric cancer
Background: Epigenetic aberrations of tumor suppressor genes (TSGs), particularly DNA methylation, are frequently involved in the pathogenesis of gastric cancer (GC). Previous studies have shown that PRDM5 is methylated and silenced in GC. However, the role of PRDM5 in GC progression has not been ex...
Autores principales: | Teng, Jing-jing, Zhao, Wen-jing, Zhang, Xun-lei, Zhao, Da-Kun, Qiu, Xin-Yue, Chen, Xu-dong, Yang, Lei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8518008/ https://www.ncbi.nlm.nih.gov/pubmed/34659579 http://dx.doi.org/10.7150/jca.59998 |
Ejemplares similares
-
Low expression of PRDM5 predicts poor prognosis of esophageal squamous cell carcinoma
por: Guo, Jing, et al.
Publicado: (2022) -
Downregulation of PSCA promotes gastric cancer proliferation and is related to poor prognosis
por: Xu, Li-pu, et al.
Publicado: (2020) -
Downregulated miR-383-5p contributes to the proliferation and migration of gastric cancer cells and is associated with poor prognosis
por: Wei, Chao, et al.
Publicado: (2019) -
Upregulator of Cell Proliferation Predicts Poor Prognosis in Hepatocellular Carcinoma and Contributes to Hepatocarcinogenesis by Downregulating FOXO3a
por: Xie, Chan, et al.
Publicado: (2012) -
The methylation profiles of PRDM promoters in non–small cell lung cancer
por: Tan, Shuang-xiang, et al.
Publicado: (2018)